Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions
about
The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidationVisualization of Content Release from Cell Surface-Attached Single HIV-1 Particles Carrying an Extra-Viral Fluorescent pH-SensorHIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA)Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: correlation with stage of disease and presence of opportunistic infection.Human follicular dendritic cells remain uninfected and capture human immunodeficiency virus type 1 through CD54-CD11a interactionEfficient infection mediated by viral receptors incorporated into retroviral particles.T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage.Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1.Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes.Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection.Minimal incidence of serum antibodies reactive with intact primary isolate virions in human immunodeficiency virus type 1-infected individualsDuring readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein.Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulationEffect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type 1 virions of different genetic clades.Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization.Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.Exogenous and endogenous hyaluronic acid reduces HIV infection of CD4(+) T cells.Pleiotropic costs of niche expansion in the RNA bacteriophage phi 6.Imaging of HIV-1 envelope-induced virological synapse and signaling on synthetic lipid bilayers.Molecular determinants of the ratio of inert to infectious virus particles.A monoclonal antibody against lymphocyte function-associated antigen-1 decreases HIV-1 replication by inducing the secretion of an antiviral soluble factor.The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope.High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse.The Role of CD44 in Disease Pathophysiology and Targeted Treatment.Mammalian Lipopolysaccharide Receptors Incorporated into the Retroviral Envelope Augment Virus Transmission.Comparison of the antibody repertoire generated in healthy volunteers following immunization with a monomeric recombinant gp120 construct derived from a CCR5/CXCR4-using human immunodeficiency virus type 1 isolate with sera from naturally infected iIncorporation of wild-type and C-terminally truncated human epidermal growth factor receptor into human immunodeficiency virus-like particles: insight into the processes governing glycoprotein incorporation into retroviral particles.LFA-1 antagonists as agents limiting human immunodeficiency virus type 1 infection and transmission and potentiating the effect of the fusion inhibitor T-20.Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations.Interaction between the cytoplasmic domain of ICAM-1 and Pr55Gag leads to acquisition of host ICAM-1 by human immunodeficiency virus type 1.Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1.Development and optimization of a sensitive pseudovirus-based assay for HIV-1 neutralizing antibodies detection using A3R5 cells.LFA-1 is a key determinant for preferential infection of memory CD4+ T cells by human immunodeficiency virus type 1.Human immunodeficiency virus type 1 replication in dendritic cell-T-cell cocultures is increased upon incorporation of host LFA-1 due to higher levels of virus production in immature dendritic cells.Glycosyl-phosphatidylinositol-Anchored Anti-HIV Env Single Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.Secondary lymphoid organ fibroblastic reticular cells mediate trans-infection of HIV-1 via CD44-hyaluronan interactions.
P2860
Q24525207-2DD88515-F0A3-4464-A7D0-9DAC52805741Q27322507-8979A710-5968-4D83-93DB-8F4FF26DCD03Q28741718-66FD0AB3-A2BC-4789-B2A5-9701AAE77B64Q33603923-3DE70590-86E9-46FF-8D00-9B87295A7FF9Q33646010-EC39FEA8-8975-4B44-B313-83FB84DC4DDFQ33782125-2B052AD2-3D41-48FF-A92E-2D73C6F5DA0FQ33782387-9354F810-0B9A-42D2-AB09-F31E75B78A0AQ33782608-6A850CEB-9963-432A-A92A-729A6115C9F0Q33783714-A6B2F4B2-6AE2-4487-9C57-960CCB39546BQ33785510-B751A299-6BD5-4928-A771-A0DCEE11D169Q33787329-6BDCF6C7-8B26-4F80-B06C-750328B3032EQ33794467-A3D1A107-85DA-49C1-A7BF-9E649BBC6DBFQ33823853-128FA266-7224-40F9-BFCA-69ACF698C38CQ33840406-C9B51653-0FB5-4C90-BF8C-C498F634E61FQ33842620-36D7DF47-F213-4DB4-872B-4BE0D12BC63CQ33853226-E40EC7AE-0D9E-47A6-83FE-7776B7AC8C25Q33873610-F007E5E4-DE80-49B9-BF51-DF960C8B327EQ34357068-FAB14353-1FD1-4B7D-B809-5652A77F1FA3Q34385257-37D2351E-F845-48FD-9D90-C9351A86DFB4Q34587807-EBEB516A-526B-46E5-AAA6-FC4254000F25Q36304403-91C1566A-D3C1-4FA2-9308-727A7FB80FC5Q36494676-88A6F90C-BFB3-445D-A4FC-E74690B627D6Q36827975-28C7695C-B2E9-448A-A023-0F2E2800C84EQ36954472-B03BE7C5-EFC1-4DAC-92E9-B30CBB347FBCQ37123276-2435AF64-C47A-49A6-84FE-FADA3B3930E8Q37796606-E1BF3529-2B36-4582-B02F-B78E86F25DEAQ38466771-6FFE41D0-E6A4-4515-B3B3-5C0A8ADE50C3Q39097992-67BB4B62-3754-44C3-B897-37BFBCC32B8DQ39549660-973A5B4D-1334-424F-9945-9B8E91041FB6Q39596501-5C2D1D0E-ADE8-4B80-A226-3EA17BA74044Q39805693-DAD27967-FBA5-4CA3-ADD4-53C2C50CE6B7Q40046367-5BB6E0B0-2B64-42F1-9816-4106EAEDC093Q40214088-368DA615-C09C-4548-BB3B-A65E8AC1DE74Q40214644-1D063776-B2E8-4499-98FB-F7B1D9D22B2BQ41933100-0E655F1F-B67B-4495-A230-9F8104BBDF5CQ42061779-A53B56C4-FA95-46FC-8561-49299A80F6D9Q42431730-28EFFFDD-892B-4E79-B857-5861971CB9D9Q47555792-D3ADB222-9FA4-446F-8D7F-9415D6040042Q55261162-8D94A388-27E6-4378-A183-3E1A4E6007BF
P2860
Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Host cell-dependent alteration ...... eficiency virus type 1 virions
@ast
Host cell-dependent alteration ...... eficiency virus type 1 virions
@en
type
label
Host cell-dependent alteration ...... eficiency virus type 1 virions
@ast
Host cell-dependent alteration ...... eficiency virus type 1 virions
@en
prefLabel
Host cell-dependent alteration ...... eficiency virus type 1 virions
@ast
Host cell-dependent alteration ...... eficiency virus type 1 virions
@en
P2093
P2860
P1433
P1476
Host cell-dependent alteration ...... eficiency virus type 1 virions
@en
P2093
P2860
P304
P407
P577
1997-05-01T00:00:00Z